U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07714187) titled 'A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides' on July 15.
Brief Summary: This study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.
Study Start Date: Jan., 2027
Study Type: INTERVENTIONAL
Condition:
Mycosis Fungoides
Cutaneous T-cell Lymphoma
Intervention:
DRUG: Duvelisib
Topical gel
Recruitment Status: NOT_YET_RECRUITING
Sponsor: SecuraBio
Published by HT Digital Content Services with permission from Health Daily Digest....